ESUN develops atomization technology to create a health ecosystem that enhances the delivery of therapeutic aerosols for respiratory treatments. This technology addresses the inefficiencies in traditional medication delivery methods, improving patient outcomes and treatment adherence.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of delivering respiratory medications via aerosols often suffer from inefficiencies, leading to suboptimal patient outcomes and reduced treatment adherence. These inefficiencies can include inconsistent particle size, poor targeting of the medication to the lungs, and significant medication waste.
Solution
ESUN is developing advanced atomization technology designed to improve the delivery of therapeutic aerosols for respiratory treatments. Their technology focuses on creating a more effective and efficient health ecosystem for aerosol medication delivery. By optimizing particle size and delivery mechanisms, ESUN aims to enhance drug deposition in the lungs, minimize medication waste, and improve overall patient outcomes. This approach seeks to address the limitations of existing aerosol delivery systems, leading to better treatment adherence and improved respiratory health.
Target Audience
The primary target audience includes patients with respiratory conditions such as asthma, COPD, and cystic fibrosis, as well as healthcare providers and pharmaceutical companies seeking to improve drug delivery methods.
Features
- Advanced atomization technology for precise aerosol generation
- Optimized particle size distribution for enhanced lung deposition
- Improved targeting mechanisms to minimize medication waste
- Integration with respiratory therapies for improved treatment outcomes